PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
1.30M / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-19.65%
Negative revenue growth while ANO.AX stands at 62.13%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-18.11%
Negative gross profit growth while ANO.AX is at 251.94%. Joel Greenblatt would examine cost competitiveness or demand decline.
-140.60%
Negative EBIT growth while ANO.AX is at 155.25%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-140.60%
Negative operating income growth while ANO.AX is at 648.74%. Joel Greenblatt would press for urgent turnaround measures.
-103.99%
Negative net income growth while ANO.AX stands at 161.71%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-100.00%
Negative EPS growth while ANO.AX is at 161.29%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-100.00%
Negative diluted EPS growth while ANO.AX is at 161.54%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-16.26%
Share reduction while ANO.AX is at 0.62%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-12.92%
Reduced diluted shares while ANO.AX is at 0.46%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-23.93%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-23.16%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-78.54%
Negative 10Y revenue/share CAGR while ANO.AX stands at 223.10%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-49.63%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
4.52%
3Y revenue/share CAGR at 50-75% of ANO.AX's 6.96%. Martin Whitman would question if the firm lags behind competitor innovations.
151.16%
10Y OCF/share CAGR above 1.5x ANO.AX's 77.99%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
407.95%
Positive OCF/share growth while ANO.AX is negative. John Neff might see a comparative advantage in operational cash viability.
31.81%
3Y OCF/share CAGR under 50% of ANO.AX's 878.66%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
98.36%
Below 50% of ANO.AX's 4293.06%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-146.54%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
84.00%
Positive short-term CAGR while ANO.AX is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1408.92%
3Y equity/share CAGR above 1.5x ANO.AX's 0.05%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.38%
Firm’s AR is declining while ANO.AX shows 53.52%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-7.37%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
4.51%
Asset growth 1.25-1.5x ANO.AX's 3.20%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
39.13%
BV/share growth above 1.5x ANO.AX's 2.14%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-58.69%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
42.47%
SG&A growth well above ANO.AX's 14.86%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.